104 related articles for article (PubMed ID: 10729206)
1. Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase.
Draper AJ; Hammock BD
Arch Biochem Biophys; 2000 Apr; 376(1):199-205. PubMed ID: 10729206
[TBL] [Abstract][Full Text] [Related]
2. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.
Tang C; Shou M; Rodrigues AD
Drug Metab Dispos; 2000 May; 28(5):567-72. PubMed ID: 10772636
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes.
Thijssen HH; Flinois JP; Beaune PH
Drug Metab Dispos; 2000 Nov; 28(11):1284-90. PubMed ID: 11038154
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
Palamanda J; Feng WW; Lin CC; Nomeir AA
Drug Metab Dispos; 2000 Jan; 28(1):38-43. PubMed ID: 10611138
[TBL] [Abstract][Full Text] [Related]
5. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
[TBL] [Abstract][Full Text] [Related]
6. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170
[No Abstract] [Full Text] [Related]
7. A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor.
Ohyama K; Nakajima M; Nakamura S; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 2000 Nov; 28(11):1303-10. PubMed ID: 11038157
[TBL] [Abstract][Full Text] [Related]
8. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9.
He M; Korzekwa KR; Jones JP; Rettie AE; Trager WF
Arch Biochem Biophys; 1999 Dec; 372(1):16-28. PubMed ID: 10562412
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P4502C11 is a target of diclofenac covalent binding in rats.
Shen S; Hargus SJ; Martin BM; Pohl LR
Chem Res Toxicol; 1997 Apr; 10(4):420-3. PubMed ID: 9114979
[TBL] [Abstract][Full Text] [Related]
10. The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells.
Slim R; Hammock BD; Toborek M; Robertson LW; Newman JW; Morisseau CH; Watkins BA; Saraswathi V; Hennig B
Toxicol Appl Pharmacol; 2001 Mar; 171(3):184-93. PubMed ID: 11243918
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s.
Moran JH; Mitchell LA; Bradbury JA; Qu W; Zeldin DC; Schnellmann RG; Grant DF
Toxicol Appl Pharmacol; 2000 Nov; 168(3):268-79. PubMed ID: 11042099
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation.
Miller JL; Trepanier LA
Eur J Clin Pharmacol; 2002 Apr; 58(1):69-72. PubMed ID: 11956677
[TBL] [Abstract][Full Text] [Related]
13. Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function.
Ridderström M; Masimirembwa C; Trump-Kallmeyer S; Ahlefelt M; Otter C; Andersson TB
Biochem Biophys Res Commun; 2000 Apr; 270(3):983-7. PubMed ID: 10772937
[TBL] [Abstract][Full Text] [Related]
14. The "albumin effect" and in vitro-in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9.
Rowland A; Elliot DJ; Knights KM; Mackenzie PI; Miners JO
Drug Metab Dispos; 2008 May; 36(5):870-7. PubMed ID: 18256202
[TBL] [Abstract][Full Text] [Related]
15. Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model.
Hutzler JM; Hauer MJ; Tracy TS
Drug Metab Dispos; 2001 Jul; 29(7):1029-34. PubMed ID: 11408370
[TBL] [Abstract][Full Text] [Related]
16. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
Deo AK; Bandiera SM
Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
18. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of monoepoxides of methyl linoleate: bioactivation and detoxification.
Greene JF; Williamson KC; Newman JW; Morisseau C; Hammock BD
Arch Biochem Biophys; 2000 Apr; 376(2):420-32. PubMed ID: 10775430
[TBL] [Abstract][Full Text] [Related]
20. Novel metabolic pathways for linoleic and arachidonic acid metabolism.
Moghaddam M; Motoba K; Borhan B; Pinot F; Hammock BD
Biochim Biophys Acta; 1996 Aug; 1290(3):327-39. PubMed ID: 8765137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
